Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1311042.RAFN5uZHLQj6ZzvAqzhtAzmNSvYuDgQA4BM-48Bd-CGRE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1311042.RAFN5uZHLQj6ZzvAqzhtAzmNSvYuDgQA4BM-48Bd-CGRE130_assertion type Assertion NP1311042.RAFN5uZHLQj6ZzvAqzhtAzmNSvYuDgQA4BM-48Bd-CGRE130_head.
- NP1311042.RAFN5uZHLQj6ZzvAqzhtAzmNSvYuDgQA4BM-48Bd-CGRE130_assertion description "[Negative results in patients with metastatic disease were associated with successful endocrine therapy and low concentrations of serum PSA, and the correlation between serum concentrations of PSA and the presence of PSA mRNA in peripheral blood was statistically significant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311042.RAFN5uZHLQj6ZzvAqzhtAzmNSvYuDgQA4BM-48Bd-CGRE130_provenance.
- NP1311042.RAFN5uZHLQj6ZzvAqzhtAzmNSvYuDgQA4BM-48Bd-CGRE130_assertion evidence source_evidence_literature NP1311042.RAFN5uZHLQj6ZzvAqzhtAzmNSvYuDgQA4BM-48Bd-CGRE130_provenance.
- NP1311042.RAFN5uZHLQj6ZzvAqzhtAzmNSvYuDgQA4BM-48Bd-CGRE130_assertion SIO_000772 7533062 NP1311042.RAFN5uZHLQj6ZzvAqzhtAzmNSvYuDgQA4BM-48Bd-CGRE130_provenance.
- NP1311042.RAFN5uZHLQj6ZzvAqzhtAzmNSvYuDgQA4BM-48Bd-CGRE130_assertion wasDerivedFrom befree-2016 NP1311042.RAFN5uZHLQj6ZzvAqzhtAzmNSvYuDgQA4BM-48Bd-CGRE130_provenance.
- NP1311042.RAFN5uZHLQj6ZzvAqzhtAzmNSvYuDgQA4BM-48Bd-CGRE130_assertion wasGeneratedBy ECO_0000203 NP1311042.RAFN5uZHLQj6ZzvAqzhtAzmNSvYuDgQA4BM-48Bd-CGRE130_provenance.